Cargando…
The Importance of Managing Modifiable Comorbidities in People with Multiple Sclerosis: A Narrative Review
Multiple sclerosis (MS) is a chronic, inflammatory, degenerative demyelinating disease of the central nervous system (CNS) of unknown etiology that affects individuals in their early adulthood. In the last decade, life expectancy for people with MS (PwMS) has almost equaled that of the general popul...
Autores principales: | Nociti, Viviana, Romozzi, Marina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10672087/ https://www.ncbi.nlm.nih.gov/pubmed/38003839 http://dx.doi.org/10.3390/jpm13111524 |
Ejemplares similares
-
Multiple Sclerosis and Autoimmune Comorbidities
por: Nociti, Viviana, et al.
Publicado: (2022) -
The Role of BDNF in Multiple Sclerosis Neuroinflammation
por: Nociti, Viviana, et al.
Publicado: (2023) -
Update on Multiple Sclerosis Molecular Biomarkers to Monitor Treatment Effects
por: Nociti, Viviana, et al.
Publicado: (2022) -
What do we know about the role of lncRNAs in multiple sclerosis?
por: Nociti, Viviana, et al.
Publicado: (2021) -
Disease-Modifying Drugs and Family Planning in People with Multiple Sclerosis: A Consensus Narrative Review from the Gulf Region
por: Alroughani, Raed, et al.
Publicado: (2020)